All features are consistent with a probable benign lesion (BIRADS III).

BI-RADS 3 carries a management recommendation of short-term follow-up. The recommendation should be for the modality or modalities that best demonstrated the initial finding.

While follow-up protocols differ across practices, a common schedule is at 6, 12, and 24 months. Once stability is documented for at least two, and at most three, years, the finding can be downgraded to BI-RADS 2 (benign). If the finding develops suspicious features, such as growth, non-circumscribed margins, or suspicious calcification morphology, then it should be upgraded to BI-RADS 4 or 5.